86860907 - PHOSPHOSYNVAX

Information

• Trademark
• 86860907

• Source

• Serial Number

  86860907

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  December 29, 2015
  8 years ago

• Transaction Date

  August 19, 2019
  4 years ago

• Status Date

  August 19, 2019
  4 years ago

• Published for Opposition Date

  May 24, 2016
  8 years ago

• Location Date

  January 29, 2019
  5 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  EINSTEIN, MATTHEW T

• Attorney Docket Number

  A09892001500

  Attorney Name

  Christina M. Licursi

  Law Office Assigned Location Code

  M60

• Owners

  • Agenus Inc.

Case File Statements

• GS0051: Pharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease

Case File Event Statements

• 8/19/2019 - 4 years ago

  39 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 8/19/2019 - 4 years ago

  38 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 1/30/2019 - 5 years ago

  37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/29/2019 - 5 years ago

  36 - EXTENSION 5 GRANTED Type: EX5G

• 1/17/2019 - 5 years ago

  35 - EXTENSION 5 FILED Type: EXT5

• 1/29/2019 - 5 years ago

  34 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 1/17/2019 - 5 years ago

  33 - TEAS EXTENSION RECEIVED Type: EEXT

• 7/13/2018 - 5 years ago

  32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/11/2018 - 5 years ago

  31 - EXTENSION 4 GRANTED Type: EX4G

• 7/11/2018 - 5 years ago

  30 - EXTENSION 4 FILED Type: EXT4

• 7/11/2018 - 5 years ago

  29 - TEAS EXTENSION RECEIVED Type: EEXT

• 1/20/2018 - 6 years ago

  28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/18/2018 - 6 years ago

  27 - EXTENSION 3 GRANTED Type: EX3G

• 1/18/2018 - 6 years ago

  26 - EXTENSION 3 FILED Type: EXT3

• 1/18/2018 - 6 years ago

  25 - TEAS EXTENSION RECEIVED Type: EEXT

• 7/21/2017 - 6 years ago

  24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/19/2017 - 6 years ago

  23 - EXTENSION 2 GRANTED Type: EX2G

• 7/19/2017 - 6 years ago

  22 - EXTENSION 2 FILED Type: EXT2

• 7/19/2017 - 6 years ago

  21 - TEAS EXTENSION RECEIVED Type: EEXT

• 1/19/2017 - 7 years ago

  20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/17/2017 - 7 years ago

  19 - EXTENSION 1 GRANTED Type: EX1G

• 1/17/2017 - 7 years ago

  18 - EXTENSION 1 FILED Type: EXT1

• 1/17/2017 - 7 years ago

  17 - TEAS EXTENSION RECEIVED Type: EEXT

• 7/19/2016 - 7 years ago

  16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 5/24/2016 - 8 years ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/24/2016 - 8 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/16/2016 - 8 years ago

  13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 5/16/2016 - 8 years ago

  12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 5/4/2016 - 8 years ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/19/2016 - 8 years ago

  10 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 4/19/2016 - 8 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 4/1/2016 - 8 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/17/2016 - 8 years ago

  7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/17/2016 - 8 years ago

  6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/17/2016 - 8 years ago

  5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/17/2016 - 8 years ago

  4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/11/2016 - 8 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/8/2016 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 1/1/2016 - 8 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP